Transcriptional complexes engaged by apo-estrogen receptor-α isoforms have divergent outcomes

被引:85
作者
Métivier, R [1 ]
Penot, G [1 ]
Carmouche, RP [1 ]
Hübner, MR [1 ]
Reid, G [1 ]
Denger, S [1 ]
Manu, D [1 ]
Brand, H [1 ]
Kos, M [1 ]
Benes, V [1 ]
Gannon, F [1 ]
机构
[1] European Mol Biol Lab, Heidelberg, Germany
关键词
ChIP; estrogen receptor; methylation; transcription; unliganded;
D O I
10.1038/sj.emboj.7600377
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Unliganded (apo-) estrogen receptor alpha (ERalpha, NR3A1) is classically considered as transcriptionally unproductive. Reassessing this paradigm demonstrated that apo- human ERalpha (ERalpha66) and its N-terminally truncated isoform (ERalpha46) are both predominantly nuclear transcription factors that cycle on the endogenous estrogen-responsive pS2 gene promoter in vivo. Importantly, isoform-specific consequences occur in terms of poising the promoter for transcription, as evaluated by determining (i) the engagement of several cofactors and the resulting nucleosomal organization; and (ii) the CpG methylation state of the pS2 promoter. Although transcriptionally unproductive, cycling of apo- ERalpha66 prepares the promoter to respond to ligand, through sequentially targeting chromatin remodeling complexes and general transcription factors. Additionally, apo-ERalpha46 recruits corepressors, following engagement of cofactors identical to those recruited by apo- ERalpha66. Together, these data describe differential activities of ERalpha isoforms. Furthermore, they depict the maintenance of a promoter in a repressed state as a cyclical process that is intrinsically dependent on initial poising of the promoter.
引用
收藏
页码:3653 / 3666
页数:14
相关论文
共 50 条
[1]  
Auwerx J, 1999, CELL, V97, P161
[2]   Transcriptional synergism on the pS2 gene promoter between a p160 coactivator and estrogen receptor-α depends on the coactivatior subtype, the type of estrogen response element, and the promoter context [J].
Barkhem, T ;
Haldosén, LA ;
Gustafsson, JÅ ;
Nilsson, S .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (11) :2571-2581
[3]   Methylation at arginine 17 of histone H3 is linked to gene activation [J].
Bauer, UM ;
Daujat, S ;
Nielsen, SJ ;
Nightingale, K ;
Kouzarides, T .
EMBO REPORTS, 2002, 3 (01) :39-44
[4]   Nuclear receptors: A rendezvous for chromatin remodeling factors [J].
Belandia, B ;
Parker, MG .
CELL, 2003, 114 (03) :277-280
[5]   Selective estrogen receptor modulators and coronary heart disease [J].
Bian, Z ;
Nilsson, S ;
Gustafsson, JÅ .
TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (05) :196-202
[6]   DNA methylation patterns and epigenetic memory [J].
Bird, A .
GENES & DEVELOPMENT, 2002, 16 (01) :6-21
[7]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[8]   Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters [J].
Caretti, G ;
Salsi, V ;
Vecchi, C ;
Imbriano, C ;
Mantovani, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (33) :30435-30440
[9]   ERα gene expression in human primary osteoblasts:: Evidence for the expression of two receptor proteins [J].
Denger, S ;
Reid, G ;
Kos, M ;
Flouriot, G ;
Parsch, D ;
Brand, H ;
Korach, KS ;
Sonntag-Buck, V ;
Gannon, F .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (12) :2064-2077
[10]   Identification of a nuclear domain with deacetylase activity [J].
Downes, M ;
Ordentlich, P ;
Kao, HY ;
Alvarez, JGA ;
Evans, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10330-10335